.Attributes Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for incorporation of patients along with MASLD and dimension of liver outcomes in cardio-- renal-- metabolic trials, when information suggest mechanistically plausible benefits and professional safety and security-- as well as describes factors for test layout as well as governing commendation.